XML 22 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance, Value at Dec. 31, 2017 $ 2,582,699 $ 117,515 $ 2,700,214 $ 28,689 $ 28,689 $ 483,733 $ 483,733 $ (386,322) $ (386,322) $ 2,456,599 $ 117,515 $ 2,574,114
Beginning Balance, Shares at Dec. 31, 2017       286,895 286,895              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201409Member                      
Net income $ 344,255                 344,255    
Net unrealized holding (loss) gain on available-for-sale securities (78)         (21)       (57)    
Common stock issued for employee stock benefit plans 40,167     $ 310   39,857            
Common stock issued for employee stock benefit plans, Shares       3,096                
Common stock issued for agency acquisitions 100,000     $ 338   99,662            
Common stock issued for agency acquisitions, Shares       3,376                
Purchase of treasury stock (100,000)         (8,750)   (91,250)        
Common stock issued to directors 700     $ 1   699            
Common stock issued to directors, Shares       13                
Cash dividends paid (84,690)                 (84,690)    
Ending Balance, Value at Dec. 31, 2018 3,000,568     $ 29,338   615,180   (477,572)   2,833,622    
Ending Balance, Shares at Dec. 31, 2018       293,380                
Net income 398,514                 398,514    
Net unrealized holding (loss) gain on available-for-sale securities 152         182       (30)    
Common stock issued for employee stock benefit plans 60,180     $ 313   59,867            
Common stock issued for employee stock benefit plans, Shares       3,129                
Common stock issued for agency acquisitions 20,000     $ 57   19,943            
Common stock issued for agency acquisitions, Shares       569                
Purchase of treasury stock (38,671)         20,000   (58,671)        
Common stock issued to directors 880     $ 3   877            
Common stock issued to directors, Shares       28                
Cash dividends paid (91,344)                 (91,344)    
Ending Balance, Value at Dec. 31, 2019 $ 3,350,279     $ 29,711   716,049   (536,243)   3,140,762    
Ending Balance, Shares at Dec. 31, 2019 281,655     297,106                
Net income $ 480,483                 480,483    
Net unrealized holding (loss) gain on available-for-sale securities 496         466       30    
Common stock issued for employee stock benefit plans 47,945     $ 184   47,761            
Common stock issued for employee stock benefit plans, Shares       1,844                
Common stock issued for agency acquisitions 30,120     $ 72   30,048            
Common stock issued for agency acquisitions, Shares       723                
Purchase of treasury stock (55,095)             (55,095)        
Common stock issued to directors 587     $ 2   585            
Common stock issued to directors, Shares       16                
Cash dividends paid (100,592)                 (100,592)    
Ending Balance, Value at Dec. 31, 2020 $ 3,754,223     $ 29,969   $ 794,909   $ (591,338)   $ 3,520,683    
Ending Balance, Shares at Dec. 31, 2020 283,004     299,689